Altimmune (ALT) Change in Taxes (2017)
Altimmune (ALT) posted quarterly Change in Taxes of -$3.2 million for Q1 2017.
Powered by 
Analysis
Altimmune (ALT) Change in Taxes (2017) Analysis & Trends
Altimmune (ALT) has reported Change in Taxes for 1 consecutive years, with -$3.2 million the latest figure, recorded in Q1 2017.
- In Q1 2017, Change in Taxes changed N/A year-over-year to -$3.2 million; the TTM figure through Dec 2025 stood at -$3.2 million (changed N/A YoY), while the FY2025 annual figure was $1.4 million, changed N/A from the prior year.
- Change in Taxes steadied at -$3.2 million in Q1 2017 per ALT's latest filing.
- Across five years, Change in Taxes topped out at -$3.2 million in Q1 2017 and bottomed at -$3.2 million in Q1 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Altimmune | 636.07 Mn | 636.07 Mn | - | - |